Scientists have conducted the largest and most diverse study to date on how recessive genetic changes contribute to developmental disorders. They found that most undiagnosed cases that are due to recessive causes are linked to genes we already know about, and suggest a shift in research focus could improve diagnosis rates.
BioAtla receives FDA fast track designation for ozuriftamab vedotin – Pharmaceutical Technology
Image credit: Shutterstock/Smart Calendar BioAtla has received a fast track designation from the US Food and Drug Administration (FDA) for its antibody drug conjugate (ADC)
July 26, 2024